In 2023, Luxembourg led global statistics, with 79.63% of its pharmaceutical science publications produced through international collaborations. Other top contributors were Estonia and Peru, showcasing a broader willingness among smaller nations to engage in cross-border scholarly exchanges. Larger countries like the United States and China exhibited significantly lower collaboration rates of 23.78% and 9.62%, respectively, indicating a potential reliance on domestic capabilities for research.
Future trends to watch include:
- An anticipated increase in collaboration driven by global health challenges.
- Potential rise in collaborations due to advancements in digital communication technologies.
- Growing emphasis on collaborative innovation in drug development to address complex diseases.
Top countries in Share of Scientific Publications Involving International Collaboration in Pharmaceutical Science by Country
| # | 10 Countries | Percent | Last Year | |
|---|---|---|---|---|
| 1 | 1 Luxembourg | 79.63 | 2023 | View data |
| 2 | 2 Estonia | 75.29 | 2023 | View data |
| 3 | 3 Peru | 74.66 | 2023 | View data |
| 4 | 4 Iceland | 65.46 | 2023 | View data |
| 5 | 5 Saudi Arabia | 64.93 | 2023 | View data |
| 6 | 6 Cyprus | 61.96 | 2023 | View data |
| 7 | 7 Denmark | 59.11 | 2023 | View data |
| 8 | 8 Austria | 56.61 | 2023 | View data |
| 9 | 9 Finland | 56.13 | 2023 | View data |
| 10 | 10 United Arab Emirates | 55.62 | 2023 | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...